Mullins R E, Langdon R G
Biochemistry. 1980 Mar 18;19(6):1199-205. doi: 10.1021/bi00547a025.
Maltosyl isothiocyanate (MITC) has been synthesized from maltose with an overall yield of 88%. It has been found to be a potent irreversible inhibitor of zero trans influx of glucose with human erythrocytes. Kinetic analysis of glucose transport after treatment of erythrocytes with MITC revealed that VT was diminished while KT was unchanged. Transportable sugars and competitive inhibitors of monosaccharide transport protected against MITC inhibition, while carbohydrates which do not interact with the transporter gave no protection. Covalent inhibitors of anion transport were without effect on glucose transport. MITC fulfilled the kinetic requirements for an affinity label of the glucose transporter of human erythrocytes [Groman, E. V., Schultz, R. M., & Engel, L. L. (1977) Methods Enzymol. 46, 54].
异硫氰酸麦芽糖苷(MITC)由麦芽糖合成,总产率为88%。已发现它是人类红细胞葡萄糖零转流入的强效不可逆抑制剂。用MITC处理红细胞后对葡萄糖转运进行动力学分析表明,最大转运速率(VT)降低而转运常数(KT)不变。可转运糖和单糖转运的竞争性抑制剂可防止MITC抑制,而不与转运体相互作用的碳水化合物则无保护作用。阴离子转运的共价抑制剂对葡萄糖转运无影响。MITC符合人类红细胞葡萄糖转运体亲和标记的动力学要求[格罗曼,E.V.,舒尔茨,R.M.,&恩格尔,L.L.(1977年)《酶学方法》46,54]。